Matches in DBpedia 2014 for { <http://dbpedia.org/resource/WAY-267,464> ?p ?o. }
Showing items 1 to 38 of
38
with 100 items per page.
- WAY-267,464 abstract "WAY-267,464 is a drug which acts as a high affinity, potent, selective, and non-peptide agonist for the oxytocin receptor, with negligible affinity for the vasopressin receptors. It has been shown to cross the blood-brain-barrier to a significantly greater extent than exogenously applied oxytocin, and in animal tests produces centrally-mediated oxytocinergic actions such as anxiolytic effects, but with no antidepressant effect evident. It was developed by a team at Ferring.".
- WAY-267,464 atcPrefix "none".
- WAY-267,464 casNumber "847375-16-0".
- WAY-267,464 iupacName "4-(3,5-dihydroxybenzyl)-N-(2-methyl-4-[(1-methyl-4,10-dihydropyrazolo[3,4-b][1,5]benzodiazepin-5(1H)-yl)carbonyl]benzyl)piperazine-1-carboxamide".
- WAY-267,464 pubchem "9938214".
- WAY-267,464 thumbnail WAY-267,464.png?width=300.
- WAY-267,464 wikiPageID "23858376".
- WAY-267,464 wikiPageRevisionID "593301398".
- WAY-267,464 atcPrefix "none".
- WAY-267,464 c "32".
- WAY-267,464 casNumber "847375".
- WAY-267,464 h "35".
- WAY-267,464 hasPhotoCollection WAY-267,464.
- WAY-267,464 iupacName "4".
- WAY-267,464 legalStatus "Uncontrolled".
- WAY-267,464 molecularWeight "581.677".
- WAY-267,464 n "7".
- WAY-267,464 o "4".
- WAY-267,464 pubchem "9938214".
- WAY-267,464 routesOfAdministration "?".
- WAY-267,464 smiles "OC1=CC=CC=C1".
- WAY-267,464 verifiedrevid "408055181".
- WAY-267,464 width "275".
- WAY-267,464 subject Category:Amides.
- WAY-267,464 subject Category:Benzodiazepines.
- WAY-267,464 subject Category:Piperazines.
- WAY-267,464 subject Category:Resorcinols.
- WAY-267,464 type Drug.
- WAY-267,464 type DrugProduct.
- WAY-267,464 type FunctionalSubstance.
- WAY-267,464 comment "WAY-267,464 is a drug which acts as a high affinity, potent, selective, and non-peptide agonist for the oxytocin receptor, with negligible affinity for the vasopressin receptors. It has been shown to cross the blood-brain-barrier to a significantly greater extent than exogenously applied oxytocin, and in animal tests produces centrally-mediated oxytocinergic actions such as anxiolytic effects, but with no antidepressant effect evident. It was developed by a team at Ferring.".
- WAY-267,464 label "WAY-267,464".
- WAY-267,464 sameAs m.076zt85.
- WAY-267,464 sameAs Q7946884.
- WAY-267,464 sameAs Q7946884.
- WAY-267,464 wasDerivedFrom WAY-267,464?oldid=593301398.
- WAY-267,464 depiction WAY-267,464.png.
- WAY-267,464 isPrimaryTopicOf WAY-267,464.